The largest database of trusted experimental protocols

Vi cell blu cell viability analyzer

Manufactured by Beckman Coulter

The Vi-CELL BLU Cell Viability Analyzer is a compact, automated device that measures cell viability and cell count. It utilizes trypan blue dye exclusion and image-based analysis to provide accurate and reliable results.

Automatically generated - may contain errors

9 protocols using vi cell blu cell viability analyzer

1

Cell Viability Measurement Using Vi-cell BLU

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell viability and VCD were measured using Vi-cell BLU Cell Viability Analyzer (Beckman Coulter). The measurement was done using either normal mode with 200 ± 20 μL of sample or a fast mode with 170 μL of sample.
+ Open protocol
+ Expand
2

Chlorite Cytotoxicity Assay in HeLa Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeLa cells were trypsinized, counted, and prepared at 105 cells/mL in normal growth media. One molar sodium chlorite stock solution was prepared fresh at the time of the assay in UltraPure ddH2O, and diluted to 2× working concentrations in cell growth media. Cells were seeded in 24-well plates, with triplicate wells for each condition. Five hundred microliters of each 2× chlorite/media preparation was first added to the plate. Five hundred microliters of cell suspension (5 × 104 cells) was then added to each well. The plate was gently mixed, and cells were grown for 3 d in a 37 °C/5% CO2 incubator. After 3 d, cells were washed briefly with 500 μL of PBS, trypsinized with 250 μL TrypLE Express, and resuspended with 750 μL of normal growth media to 1 mL total volume. In wells containing a majority of visibly dead, floating cells, cells were resuspended by vigorously pipetting up and down rather than by trypsinization. Two hundred microliters of each cell suspension was then quantified using a Vi-Cell BLU Cell Viability Analyzer (Beckman Coulter).
+ Open protocol
+ Expand
3

AREG Neutralization Impacts Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were plated in their respective maintenance media conditions at a density of 50,000 cells/well in 12-well plates. 24 hours following seeding, cells were treated with 1, 3, or 5 μg of AREG neutralizing antibody (R&D Systems, MAB262-SP) or an equivalent volume of PBS. This experiment was performed with three replicates for each cell line and each treatment condition. Cells were counted and viability was measured 72 hours following treatment using a Vi-CELL BLU cell viability analyzer (Beckman Coulter).
+ Open protocol
+ Expand
4

Cell proliferation assay for MCF-10A knockouts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Exponentially growing MCF-10A cells of each knockout genotype were plated at 2 × 103 cells per well in six-well plates. On indicated days, cells were counted using a Beckman Coulter Vi-Cell BLU Cell Viability Analyzer. All cell lines were counted in triplicate.
+ Open protocol
+ Expand
5

AREG Neutralization Impacts Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were plated in their respective maintenance media conditions at a density of 50,000 cells/well in 12-well plates. 24 h following seeding, cells were treated with 1, 3, or 5 µg of AREG neutralizing antibody (R&D Systems, MAB262-SP) or an equivalent volume of PBS. This experiment was performed with three replicates for each cell line and each treatment condition. Cells were counted and viability was measured 72 h following treatment using a Vi-CELL BLU cell viability analyzer (Beckman Coulter).
+ Open protocol
+ Expand
6

Isolation and Analysis of Murine Splenocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant MHV68 expressing H2bYFP fusion protein (rMHV68-H2bYFP) was used for the infection (107 (link)). Mice (8 to 12 weeks old) were infected by intraperitoneal injection with 1,000 PFU in 0.5 ml under isoflurane anesthesia. Mouse spleens were homogenized, treated to remove red blood cells, and passed through a 100-µm-pore-size nylon filter. For ex vivo experiments, flow sorting, and RNA-sequencing, splenocytes were subject to negative selection to enrich for B cells (Pan B cell isolation kit; STEMCELL, Vancouver, BC, Canada). Cells were counted using Vi-CELL BLU Cell Viability Analyzer (Beckman Coulter, Pasadena, CA). Blood was collected posthumously by cardiac puncture with gauge 27 needle. Serum was collected after a centrifugation at 20,000 x g for 20 mins at room temperature.
+ Open protocol
+ Expand
7

Cell Viability Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lines were maintained and treated as previously described (Cell culture with drug). 100,000 cells/well were plated in a 6-well plate, on Day 0, and cells began treatment 24 or 72 hours later (in accordance with Cell culture with drug). Three wells of cells were trypsinized and collected (per cell line and treatment) every 2 days. Cells were then counted via trypan blue exclusion using the Beckman Coulter Vi-CELL BLU Cell Viability Analyzer (Beckman Coulter Life Sciences).
+ Open protocol
+ Expand
8

Cell Viability Analysis of LAA + Olaparib

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell density data was acquired from cells treated with LAA + Olaparib for 72hr. Cells were sampled on a Vi-CELL BLU Cell Viability Analyzer (Beckman). 100 images acquired per sample, diameter 6–30μm, cell sharpness 7, minimum circularity, medium decluster degree, 3 aspiration and mixing cycles, 50% viable spot brightness, and 5% viable spot area.
+ Open protocol
+ Expand
9

Cell Viability Assay with Trypan Blue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lines were maintained and treated as previously described (Cell Culture with Drug). 100,000 cells/well were plated in a 6-well plate, on Day 0, and cells began treatment 24 or 72 hours later (in accordance with “Cell Culture with Drug”). 3 wells of cells were trypsinized and collected (per cell line and treatment) every 2 days. Cells were then counted via trypan blue exclusion using the Beckman Coulter Vi-CELL BLU Cell Viability Analyzer (Beckman Coulter Life Sciences).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!